Loading...
Advancing the global public health agenda for NAFLD: a consensus statement
Зохиогч
Jeffrey Victor Lazarus
Henry E. Mark
Quentin Mark Anstee
Juan Pablo Arab
Rachel Louise Batterham
Laurent Castéra
Helena Cortez‐Pinto
Javier Crespo
Kenneth J. Cusi
Maegan Ashworth Dirac
Sven Francque
Jacob George
Hannes Hagström
Terry T.‐K. Huang
Mona Hassan Ismail
Achim Kautz
Shiv Kumar Sarin
Rohit Seth Loomba
Veronica Miller
Philip Noel Newsome
Michael H. Ninburg
Ponsiano Ocama
Vlad Ratziu
Mary Eugenia Rinella
Diana Romero
Manuel Romero‐Gómez
Jörn Markus Schattenberg
Emmanuel A. Tsochatzis
Luca V. C. Valenti
Vincent Wai‐Sun Wong
Yusuf Nadir Yilmaz
Zobair M. Younossi
Shira Zelber‐Sagi
Fredrik O. Åberg
Leon Anton Adams
Maryam Al Khatry
Khalid Al Naamani
Omar Alfaro Murillo
Alina M. Allen
Faisal Abdullatif Alnasir
Saleh A. Alqahtani
Khalid Alswat
Domenico Alvaro
Raúl J. Andrade
Marco A. Arrese
Yaw Asante Awuku
Motala Ayesha
Shokhista Bakieva
Rita Basu
Ramon A. Bataller
Shahinaz Ahmed Bedri
Emanuele Bosi
Marc Bourlière
Radan Brůha
Elisabetta Bugianesi
Patrizia Burra
Marı́a Buti
Christopher D. Byrne
José Luís Calleja
Patrizia Carrieri
Flloyd Carter
Marlén Ivón Castellanos Fernández
Gabriela Castillo-Lopez
Graciela Castro‐Narro
Henry Lik‐Yuen Chan
Wah‐Kheong Chan
Yoosoo Chang
Massimo Giuseppe Colombo
Kirsten J. Coppell
Kathleen E. Corey
Antonio Craxı̀
Donna R. H. Cryer
Anuradha Supun Dassanayake
Antonieta Soares Martins
Victor de Lédinghen
Stefano DelPrato
Sandro Demaio
Hailemichael Desalegn
John Dillon
Ajay Kumar. Duseja
Prabhakaran Dorairaj
Mattias Ekstedt
Mohamed El‐Kassas
Osama Mohamed Elsanousi
Gamal Esmat
Jian‐Gao Fan
Nathalie J. Farpour‐Lambert
Robert Flisiak
Yasser Mahrous Fouad
Michael Fuchs
Rino Alvani Gani
Lynn H. Gerber
Hasmik Ghazinyan
Liana S. Gheorghe
George Boon‐Bee Goh
Henning Grønbæk
Aghayeva Gulnara
Saeed Sadiq Hamid
Vanessa Hebditch
Он
2021 оны аравдугаар сарын 27
Төрөл
review article
Хэвлэгч
Nature Portfolio
Journal
Nature Reviews Gastroenterology & Hepatology
Volume
19
Issue
1
Start Page
60
End Page
78
ISSN
1759-5045
1759-5053
Хураангуй
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics — from epidemiology, awareness, care and treatment to public health policies and leadership — that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD. Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease with a substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts develop consensus statements and recommendations addressing a broad range of topics on NAFLD to raise awareness and spur action.